Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan, Jessica C. Hassel, Piotr Rutkowski, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 13, pp. 1196-1206
Open Access | Times Cited: 625

Showing 51-75 of 625 citing articles:

Application of machine learning in predicting survival outcomes involving real-world data: a scoping review
Yinan Huang, Jieni Li, Mai Suan Li, et al.
BMC Medical Research Methodology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 28
Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer
Diana Simão, Kevin Zarrabi, José Leão Mendes, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1412-1412
Open Access | Times Cited: 27
Current management of uveal melanoma: A review
Hai-Xia Bai, Jacobus Bosch, Ludwig M. Heindl
Clinical and Experimental Ophthalmology (2023) Vol. 51, Iss. 5, pp. 484-494
Open Access | Times Cited: 26
Precision cancer medicine: Concepts, current practice, and future developments
Anders Edsjö, Louise Holmquist, Birgit Geoerger, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 455-481
Open Access | Times Cited: 26
Uveal melanoma: In the era of new treatments
Mylène Wespiser, Ève-Marie Neidhardt, Sylvie Négrier
Cancer Treatment Reviews (2023) Vol. 119, pp. 102599-102599
Closed Access | Times Cited: 23
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
Jonathan S. Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 8, pp. 5340-5351
Open Access | Times Cited: 16
Immunotherapy resistance in solid tumors: mechanisms and potential solutions
Daniel S. Lefler, Steven Manobianco, Babar Bashir
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 15
15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)
J. William Harbour, Zélia M. Corrêa, Amy C. Schefler, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 28, pp. 3319-3329
Open Access | Times Cited: 15
Bispecific antibodies: advancing precision oncology
M. Zurita Herrera, G. Pretelli, Jayesh Desai, et al.
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 893-919
Open Access | Times Cited: 15
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors
Jim Middelburg, Marjolein Sluijter, Gaby Schaap, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Uveal melanoma: Current evidence on prognosis, treatment and potential developments
Maria C. Gelmi, Martine J. Jager
Asia-Pacific Journal of Ophthalmology (2024) Vol. 13, Iss. 2, pp. 100060-100060
Open Access | Times Cited: 12
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma
Elizabeth I. Buchbinder, Justine V. Cohen, Giuseppe Tarantino, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 5, pp. 1321-1327
Open Access | Times Cited: 12
The potential and promise for clinical application of adoptive T cell therapy in cancer
Yinqi Li, Yeteng Zheng, Taiqing Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies
Florian Moik, Jakob M. Riedl, Cornelia Englisch, et al.
Hämostaseologie (2024) Vol. 44, Iss. 01, pp. 040-048
Open Access | Times Cited: 11
Single-cell RNA sequencing in melanoma: what have we learned so far?
Su Yin Lim, Helen Rizos
EBioMedicine (2024) Vol. 100, pp. 104969-104969
Open Access | Times Cited: 11
Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy
Megan Yuan, Wenjun Wang, Isobel Hawes, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
Shravan Leonard‐Murali, Chetana Bhaskarla, Ghanshyam S. Yadav, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy
Ali Zarezadeh Mehrabadi, Mahdi Tat, Akbar Ghorbani Alvanegh, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial
Emily K. Ninmer, Hong Zhu, Kimberly A. Chianese‐Bullock, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison
Linyan Cheng, Lujun Chen, Yuan Shi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
Arthur Géraud, Thomas Hueso, Ariane Laparra, et al.
European Journal of Cancer (2024) Vol. 205, pp. 114075-114075
Closed Access | Times Cited: 9
Next-generation combination approaches for immune checkpoint therapy
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 9
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024
Claus Garbe, Teresa Amaral, Ketty Peris, et al.
European Journal of Cancer (2024) Vol. 215, pp. 115153-115153
Open Access | Times Cited: 9
Multifunctional Thermoelectric Nanocatalysts for Synergistic Uveal Melanoma Treatment by Specific Cuproptosis and Pyroptosis
Muyue Yang, Xiaoyan Jiang, Mingyang Song, et al.
Advanced Functional Materials (2025)
Closed Access | Times Cited: 1
Non-Cutaneous Melanoma
Leanne Brown, Kelly Olino
Surgical Oncology Clinics of North America (2025)
Closed Access | Times Cited: 1

Scroll to top